7Baggers
 Oramed Pharmaceuticals (ORMP) Receives $13 Million from Scilex f  GuruFocus Wed, 01 Oct 2025 14:08:06 GMT
 Scilex completes first tranche of Oramed warrant repurchase  TipRanks Wed, 01 Oct 2025 13:09:22 GMT
 published on: 2025-09-04 00:33:56  Newser Thu, 04 Sep 2025 05:33:56 GMT
 published on: 2025-08-31 00:33:28  Newser Sun, 31 Aug 2025 05:33:28 GMT
 published on: 2025-08-30 20:57:05  Newser Sun, 31 Aug 2025 01:57:05 GMT
 published on: 2025-08-30 13:05:34  Newser Sat, 30 Aug 2025 18:05:34 GMT
 published on: 2025-08-29 18:16:48  Newser Fri, 29 Aug 2025 23:16:48 GMT
 published on: 2025-08-28 22:30:05  Newser Fri, 29 Aug 2025 03:30:05 GMT
 published on: 2025-08-28 15:04:36  Newser Thu, 28 Aug 2025 20:04:36 GMT
 published on: 2025-08-28 14:30:33  Newser Thu, 28 Aug 2025 19:30:33 GMT
 published on: 2025-08-28 13:31:49  Newser Thu, 28 Aug 2025 18:31:49 GMT
 published on: 2025-08-28 02:07:46  Newser Thu, 28 Aug 2025 07:07:46 GMT
 published on: 2025-08-27 11:55:38  Newser Wed, 27 Aug 2025 16:55:38 GMT
 published on: 2025-08-26 21:16:57  Newser Wed, 27 Aug 2025 02:16:57 GMT
 published on: 2025-08-26 06:03:19  Newser Tue, 26 Aug 2025 11:03:19 GMT
 published on: 2025-08-25 02:09:51  Newser Mon, 25 Aug 2025 07:09:51 GMT
 oramed pharm approves stock incentive plan amendment  MSN Sun, 24 Aug 2025 18:39:50 GMT
 published on: 2025-08-24 06:16:05  Newser Sun, 24 Aug 2025 11:16:05 GMT

Oramed Pharmaceuticals Inc
(NASDAQ:ORMP) 

ORMP stock logo

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, ...

Founded: 2006
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends